About that whole Shortage thing The interesting dynamic at play here isHims doesnt share investor concerns around the massive business risk associated with compounding GLP-1s during a shortage and capitalizing on a technicality
Nasseris care, youll receive more than just a treatment youll receive a personalized wellness plan designed to help you feel rejuvenated
These include severe abdominal pain, persistent vomiting with inability to tolerate fluids, visual changes (especially for people with diabetes and existing retinopathy), signs of allergic reaction (rash, difficulty breathing, facial swelling), right upper quadrant pain with fever or jaundice (possible gallbladder disease), or symptoms of thyroid tumors (neck mass, hoarseness, difficulty swallowing)
Research peptide vendors are chemical suppliers, not pharmacies
A public benefit corporation, the pharmacy and drug wholesale companydescribing itself as an UnPBMaims to slash prescription prices by filling and delivering scripts at acquisition cost plus a fixed 15% margin